pre-miRNA Information
pre-miRNA hsa-mir-2110   
Genomic Coordinates chr10: 114174105 - 114174179
Synonyms hsa-mir-2110, MIR2110
Description Homo sapiens miR-2110 stem-loop
Comment Zhu et al. incorrectly referred to this sequence as mir-1309 in . This sequence is unrelated to MIR1309 in plants.
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-2110
Sequence 8| UUGGGGAAACGGCCGCUGAGUG |29
Evidence Experimental
Experiments 454
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN31660996 18 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1434681640 4 dbSNP
rs1418383763 6 dbSNP
rs745914474 7 dbSNP
rs1178383827 8 dbSNP
rs1412803607 9 dbSNP
rs114530801 10 dbSNP
rs1168982220 11 dbSNP
rs573692968 14 dbSNP
rs1246581316 15 dbSNP
rs1431021422 16 dbSNP
rs1188283086 17 dbSNP
rs1476834649 19 dbSNP
rs192664871 19 dbSNP
Putative Targets

miRNA Expression profile
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol HLA-A   
Synonyms HLAA
Description major histocompatibility complex, class I, A
Transcript NM_002116   
Expression
Putative miRNA Targets on HLA-A
3'UTR of HLA-A
(miRNA target sites are highlighted)
>HLA-A|NM_002116|3'UTR
   1 GACAGCTGCCTTGTGTGGGACTGAGAGGCAAGAGTTGTTCCTGCCCTTCCCTTTGTGACTTGAAGAACCCTGACTTTGTT
  81 TCTGCAAAGGCACCTGCATGTGTCTGTGTTCGTGTAGGCATAATGTGAGGAGGTGGGGAGACCACCCCACCCCCATGTCC
 161 ACCATGACCCTCTTCCCACGCTGACCTGTGCTCCCTCCCCAATCATCTTTCCTGTTCCAGAGAGGTGGGGCTGAGGTGTC
 241 TCCATCTCTGTCTCAACTTCATGGTGCACTGAGCTGTAACTTCTTCCTTCCCTATTAAAATTAGAACCTTAGTATAAATT
 321 TACTTTCTCAAATTCTTGCCATGAGAGGTTGATGAGTTAATTAAAGGAGAAGATTCCTAAAATTTGAGAGACAAAATAAA
 401 TGGAAGACATGAGAACCTTCCAGAGTCCAAAAAAAAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' guGAGUCGCC-----GGCA--AAGGGGUu 5'
            || ||| |     :| |  |||||:| 
Target 5' caCTGAGCTGTAACTTCTTCCTTCCCTAt 3'
267 - 295 130.00 -13.80
2
miRNA  3' gugagucgccggcaaAGGGGUu 5'
                         |||||| 
Target 5' ctgacctgtgctcccTCCCCAa 3'
181 - 202 120.00 -14.60
3
miRNA  3' guGAGUCGCCGGCAAAGGGGuu 5'
            :||  | |||  |||||:  
Target 5' tgTTC--CTGCC-CTTCCCTtt 3'
36 - 54 111.00 -9.40
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
29755 67 ClinVar
COSN26978905 18 COSMIC
COSN30526302 24 COSMIC
COSN30145701 26 COSMIC
COSN17134393 35 COSMIC
COSN20476147 43 COSMIC
COSN19631150 51 COSMIC
COSN26978904 66 COSMIC
COSN17134460 67 COSMIC
COSN20476148 75 COSMIC
COSN20476149 79 COSMIC
COSN30188260 88 COSMIC
COSN31581613 102 COSMIC
COSN15656245 113 COSMIC
COSN1330872 122 COSMIC
COSN1330873 124 COSMIC
COSN19620218 136 COSMIC
COSN28773765 139 COSMIC
COSN30498797 145 COSMIC
COSN19631151 146 COSMIC
COSN19631086 152 COSMIC
COSN30518887 181 COSMIC
COSN15653401 199 COSMIC
COSN20075704 206 COSMIC
COSN28645313 218 COSMIC
COSN27602173 237 COSMIC
COSN6513647 264 COSMIC
rs1061235 67 GWAS
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1255082501 10 dbSNP
rs1177032289 14 dbSNP
rs1484382958 15 dbSNP
rs752204014 17 dbSNP
rs200105102 20 dbSNP
rs45502194 26 dbSNP
rs1487958414 29 dbSNP
rs1190937442 30 dbSNP
rs1207148423 33 dbSNP
rs1243570672 34 dbSNP
rs1061156 35 dbSNP
rs1168668342 38 dbSNP
rs771413680 42 dbSNP
rs572407231 43 dbSNP
rs149604815 44 dbSNP
rs1376588533 45 dbSNP
rs746262450 51 dbSNP
rs1372238184 52 dbSNP
rs10853 59 dbSNP
rs200062476 63 dbSNP
rs45574131 66 dbSNP
rs1061235 67 dbSNP
rs1444122973 69 dbSNP
rs1357293904 70 dbSNP
rs1451946086 73 dbSNP
rs372982354 75 dbSNP
rs375982247 79 dbSNP
rs1396948741 87 dbSNP
rs1156974002 93 dbSNP
rs1479545179 93 dbSNP
rs1418716379 96 dbSNP
rs769833442 101 dbSNP
rs1409063728 106 dbSNP
rs578027483 112 dbSNP
rs13395 113 dbSNP
rs1469710052 116 dbSNP
rs1157312752 118 dbSNP
rs386698558 121 dbSNP
rs796763843 122 dbSNP
rs796782603 124 dbSNP
rs181754482 134 dbSNP
rs1307263839 135 dbSNP
rs548664078 135 dbSNP
rs113042145 136 dbSNP
rs1353356457 138 dbSNP
rs763522908 141 dbSNP
rs386698559 142 dbSNP
rs1061815 143 dbSNP
rs41540713 144 dbSNP
rs376071102 146 dbSNP
rs547626665 148 dbSNP
rs879755443 149 dbSNP
rs367837921 152 dbSNP
rs1360144630 153 dbSNP
rs41545022 155 dbSNP
rs1289240412 156 dbSNP
rs1417552282 161 dbSNP
rs202133784 165 dbSNP
rs977990404 171 dbSNP
rs923836459 180 dbSNP
rs1197721184 181 dbSNP
rs539771433 194 dbSNP
rs112863520 199 dbSNP
rs1332278838 202 dbSNP
rs186532503 203 dbSNP
rs1233739663 212 dbSNP
rs66585529 218 dbSNP
rs1293360823 220 dbSNP
rs1445709210 221 dbSNP
rs1362721970 223 dbSNP
rs1290748474 229 dbSNP
rs1460065421 230 dbSNP
rs199807456 237 dbSNP
rs1166032175 245 dbSNP
rs1463348170 247 dbSNP
rs79244404 252 dbSNP
rs572546465 253 dbSNP
rs1215076505 255 dbSNP
rs1432044073 262 dbSNP
rs201469499 264 dbSNP
rs144149732 270 dbSNP
rs879593791 278 dbSNP
rs112525507 284 dbSNP
rs145464605 287 dbSNP
rs1252009151 288 dbSNP
rs1382890622 291 dbSNP
rs1245104283 292 dbSNP
rs201615458 295 dbSNP
rs1344009048 305 dbSNP
rs577937205 308 dbSNP
rs1308070709 309 dbSNP
rs2499 311 dbSNP
rs9385 323 dbSNP
rs1370439494 332 dbSNP
rs1194312896 337 dbSNP
rs573809399 357 dbSNP
rs1443507957 368 dbSNP
rs1394757478 395 dbSNP
rs866524175 398 dbSNP
rs2975053 399 dbSNP
rs1171837912 401 dbSNP
rs1452040407 402 dbSNP
rs1386913013 403 dbSNP
rs386698560 406 dbSNP
rs879714036 406 dbSNP
rs13488 407 dbSNP
rs2975052 408 dbSNP
rs370789221 410 dbSNP
rs368263062 411 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gugagucgccggcaaAGGGGUu 5'
                         |||||| 
Target 5' ---accugugcucccUCCCCAa 3'
1 - 19
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM4903825
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / PID14_NS
Location of target site NM_002116 | 3UTR | GAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCCAUCUCUGUCUCAACUUCAUGGUGCACUGAGCUGUAAC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161237
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM4903826
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / PID21_NS
Location of target site NM_002116 | 3UTR | ACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCCAUCUCUGUCUCAACUUCAUGGUGCACUGAGCUGUAACUUCUUCCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161237
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM4903833
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_a
Location of target site NM_001242758 | 3UTR | GUGUAGGCAUAAUGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM4903834
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_b
Location of target site NM_001242758 | 3UTR | UCUGUGUUCGUGUAGGCAUAAUGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCCAUCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM4903835
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_c
Location of target site NM_001242758 | 3UTR | UGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCCAUC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 6 for dataset GSM4903836
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_a
Location of target site NM_001242758 | 3UTR | UGUCUGUGUUCGUGUAGGCAUAAUGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 7 for dataset GSM4903837
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_b
Location of target site NM_001242758 | 3UTR | GUCUGUGUUCGUGUAGGCAUAAUGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGUGUCUCCAUCUCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 8 for dataset GSM4903838
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_c
Location of target site NM_001242758 | 3UTR | UGUGUUCGUGUAGGCAUAAUGUGAGGAGGUGGGGAGACCACCCCACCCCCAUGUCCACCAUGACCCUCUUCCCACGCUGACCUGUGCUCCCUCCCCAAUCAUCUUUCCUGUUCCAGAGAGGUGGGGCUGAGGU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 9 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000396634.1 | 3UTR | ACCUGUGCUCCCUCCCCAAUCAUCUUUCCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
KIRP 0.398 0.01 0.291 0.06 30 Click to see details
UCEC -0.488 0.02 -0.544 0.01 18 Click to see details
HNSC 0.311 0.03 0.325 0.02 39 Click to see details
LUSC -0.257 0.09 -0.145 0.23 29 Click to see details
PAAD -0.956 0.09 -1.000 0.5 3 Click to see details
KIRC 0.153 0.14 0.113 0.21 53 Click to see details
PRAD -0.189 0.14 -0.173 0.16 35 Click to see details
COAD 0.895 0.15 0.500 0.33 3 Click to see details
STAD 0.193 0.15 0.227 0.11 30 Click to see details
CESC 0.736 0.24 0.500 0.33 3 Click to see details
BLCA 0.192 0.25 0.229 0.21 15 Click to see details
LIHC 0.06 0.35 0.054 0.36 45 Click to see details
THCA -0.044 0.37 -0.021 0.44 58 Click to see details
KICH 0.066 0.38 -0.003 0.49 24 Click to see details
BRCA 0.031 0.41 0.019 0.44 58 Click to see details
PCPG -0.269 0.41 -0.500 0.33 3 Click to see details
ESCA -0.067 0.42 -0.145 0.34 11 Click to see details
CHOL 0.051 0.46 -0.086 0.44 6 Click to see details
LUAD 0.005 0.49 0.028 0.47 12 Click to see details
LUAD 0.005 0.49 0.028 0.47 12 Click to see details
LUAD 0.005 0.49 0.028 0.47 12 Click to see details
96 hsa-miR-2110 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT035757 BRD4 bromodomain containing 4 1 1
MIRT035758 NCOR2 nuclear receptor corepressor 2 1 1
MIRT035759 FASN fatty acid synthase 1 1
MIRT035760 C10orf118 coiled-coil domain containing 186 1 1
MIRT055403 SHOC2 SHOC2, leucine rich repeat scaffold protein 2 6
MIRT066205 MARCH9 membrane associated ring-CH-type finger 9 2 2
MIRT079365 CCDC137 coiled-coil domain containing 137 2 2
MIRT081180 MIDN midnolin 2 4
MIRT082397 HNRNPUL1 heterogeneous nuclear ribonucleoprotein U like 1 2 4
MIRT089000 BCL11A B-cell CLL/lymphoma 11A 2 2
MIRT133706 SKI SKI proto-oncogene 2 4
MIRT160053 TET3 tet methylcytosine dioxygenase 3 2 4
MIRT180853 RPRD2 regulation of nuclear pre-mRNA domain containing 2 2 2
MIRT263243 SGPL1 sphingosine-1-phosphate lyase 1 2 2
MIRT285532 CDT1 chromatin licensing and DNA replication factor 1 2 2
MIRT317152 E2F3 E2F transcription factor 3 2 4
MIRT321166 EIF4H eukaryotic translation initiation factor 4H 2 2
MIRT441482 NCEH1 neutral cholesterol ester hydrolase 1 2 2
MIRT443884 CNKSR3 CNKSR family member 3 2 2
MIRT445877 WBP1L WW domain binding protein 1 like 2 2
MIRT446195 GTPBP4 GTP binding protein 4 2 2
MIRT449308 MRO maestro 2 2
MIRT450301 DRAXIN dorsal inhibitory axon guidance protein 2 2
MIRT450512 EMX1 empty spiracles homeobox 1 2 2
MIRT451534 CIAPIN1 cytokine induced apoptosis inhibitor 1 2 2
MIRT451820 ALDH3B1 aldehyde dehydrogenase 3 family member B1 2 2
MIRT452239 TRAM1 translocation associated membrane protein 1 2 2
MIRT454207 HLA-A major histocompatibility complex, class I, A 2 2
MIRT455447 EPB41L4B erythrocyte membrane protein band 4.1 like 4B 2 2
MIRT456496 PFKFB2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 2 2
MIRT457656 SERINC1 serine incorporator 1 2 2
MIRT459819 TPP1 tripeptidyl peptidase 1 2 2
MIRT460556 FEM1A fem-1 homolog A 2 2
MIRT462561 STS steroid sulfatase 2 2
MIRT462986 ZNF740 zinc finger protein 740 2 2
MIRT464671 UBE2V1 ubiquitin conjugating enzyme E2 V1 2 2
MIRT465432 TP53 tumor protein p53 2 2
MIRT465934 TMEM189-UBE2V1 TMEM189-UBE2V1 readthrough 2 2
MIRT466015 TMEM189 transmembrane protein 189 2 2
MIRT468122 SH3PXD2A SH3 and PX domains 2A 2 2
MIRT469652 RAC1 Rac family small GTPase 1 2 2
MIRT469980 PTPN14 protein tyrosine phosphatase, non-receptor type 14 2 2
MIRT473531 MAX MYC associated factor X 2 2
MIRT473596 MARK2 microtubule affinity regulating kinase 2 2 2
MIRT473652 MARCKSL1 MARCKS like 1 2 2
MIRT474219 LCOR ligand dependent nuclear receptor corepressor 2 4
MIRT474771 KIAA0895L KIAA0895 like 2 2
MIRT479312 VPS72 vacuolar protein sorting 72 homolog 2 2
MIRT481121 AZIN1 antizyme inhibitor 1 2 4
MIRT481682 AR androgen receptor 2 2
MIRT482381 AEN apoptosis enhancing nuclease 2 2
MIRT483833 UNC5B unc-5 netrin receptor B 2 4
MIRT484693 RNF11 ring finger protein 11 2 2
MIRT485238 POGZ pogo transposable element derived with ZNF domain 2 2
MIRT488748 FXYD1 FXYD domain containing ion transport regulator 1 2 2
MIRT489147 MRPL12 mitochondrial ribosomal protein L12 2 4
MIRT489518 MRE11A MRE11 homolog, double strand break repair nuclease 2 8
MIRT498908 SRCAP Snf2 related CREBBP activator protein 2 2
MIRT506426 NAGK N-acetylglucosamine kinase 2 6
MIRT506640 MAPK1 mitogen-activated protein kinase 1 2 4
MIRT507332 FAM168A family with sequence similarity 168 member A 2 2
MIRT513099 DYNAP dynactin associated protein 2 2
MIRT513514 YIPF4 Yip1 domain family member 4 2 6
MIRT521800 POM121C POM121 transmembrane nucleoporin C 2 2
MIRT525078 FRK fyn related Src family tyrosine kinase 2 2
MIRT530927 SCIN scinderin 2 2
MIRT533498 TRIM71 tripartite motif containing 71 2 2
MIRT536787 HNRNPD heterogeneous nuclear ribonucleoprotein D 2 2
MIRT544554 CSNK2A1 casein kinase 2 alpha 1 2 2
MIRT552977 VAT1 vesicle amine transport 1 2 2
MIRT557358 HAND1 heart and neural crest derivatives expressed 1 2 2
MIRT560401 TMEM69 transmembrane protein 69 2 2
MIRT565498 SP1 Sp1 transcription factor 2 2
MIRT568962 CACNA1C calcium voltage-gated channel subunit alpha1 C 2 2
MIRT569031 IL21R interleukin 21 receptor 2 2
MIRT573224 TRIM21 tripartite motif containing 21 2 2
MIRT574312 ZNF703 zinc finger protein 703 2 2
MIRT620395 MYO1H myosin IH 2 2
MIRT620936 OSMR oncostatin M receptor 2 2
MIRT638166 TMED4 transmembrane p24 trafficking protein 4 2 2
MIRT647743 SAMD9L sterile alpha motif domain containing 9 like 2 2
MIRT649991 MSI1 musashi RNA binding protein 1 2 2
MIRT669203 CBX8 chromobox 8 2 2
MIRT684546 ZNF708 zinc finger protein 708 2 2
MIRT685837 ANGEL1 angel homolog 1 2 2
MIRT688547 DCAF16 DDB1 and CUL4 associated factor 16 2 2
MIRT693252 HBS1L HBS1 like translational GTPase 2 2
MIRT701970 MIER3 MIER family member 3 2 2
MIRT706385 MC2R melanocortin 2 receptor 2 2
MIRT707484 UGT2B4 UDP glucuronosyltransferase family 2 member B4 2 2
MIRT711882 INSIG2 insulin induced gene 2 2 2
MIRT716906 CACNB2 calcium voltage-gated channel auxiliary subunit beta 2 2 2
MIRT717638 HLX H2.0 like homeobox 2 2
MIRT719058 ZNF281 zinc finger protein 281 2 2
MIRT723754 NKIRAS2 NFKB inhibitor interacting Ras like 2 2 2
MIRT725479 GPR26 G protein-coupled receptor 26 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-2110 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (SGC-7901)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved sensitive Low Cervical Cancer tissue
hsa-miR-2110 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (AsPC-1)
hsa-mir-2110 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-2110 Paclitaxel 36314 NSC125973 approved sensitive cell line (W1)
hsa-mir-2110 Cisplatin 5460033 NSC119875 approved sensitive cell line (W1)
hsa-mir-2110 Methotrexate 126941 NSC740 approved sensitive cell line (W1)
hsa-mir-2110 Vincristine 5978 approved sensitive cell line (W1)
hsa-mir-2110 Topotecan 60699 NSC609699 approved sensitive cell line (W1)
hsa-mir-2110 Paclitaxel 36314 NSC125973 approved resistant cell line (A2780)
hsa-mir-2110 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-2110 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-2110 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-2110 Cisplatin 5460033 NSC119875 approved resistant cell line (SGC-7901)
hsa-miR-2110 Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-2110 Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-2110 Paclitaxel 36314 NSC125973 approved sensitive cell line (BAS)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-2110 Tamoxifen 2733525 NSC180973 approved resistant cell line (LCC2)
hsa-miR-2110 Tamoxifen+Fulvestrant resistant cell line (LCC9)
hsa-miR-2110 Paclitaxel 36314 NSC125973 approved resistant cell line (A2780)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved resistant cell line (MGC-803)
hsa-miR-2110 Pegylated interferon alpha+Ribavirin sensitive tissue (chronic hepatitis C)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-2110 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved resistant cell line (TOV-112D)
hsa-miR-2110 Cisplatin 5460033 NSC119875 approved resistant cell line (OVSAHO)

Error report submission